Table 6 ICU outcome survival.

From: Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome

 

Survivors

Non-survivors

p

n

90

94

 

Duration of hospital stay [days]

19 (14; 27)

19 (14; 29)

 

Duration of ANE-ICU stay [days]

14 (8; 19)

13 (9; 18)

 

Duration of stay at UKD [days]

22 (15; 30)

14 (9; 20)

 

VTE during ICU stay

37 (41.1%)

48 (51.1%)

 

DVT

24 (26.7%)

34 (36.2%)

 

Catheter associated thrombosis

2 (2.2%)

3 (3.2%)

 

PE

25 (27.8%)

32 (34.0%)

 

VTE before ICU admission

8 (8.9%)

9 (9.6%)

 

Pneumothorax

8 (8.9%)

14 (15.1%)

 

Lung emphysema

2 (2.2%)

7 (7.5%)

 

Mediastinal emphysema

3 (3.3%)

10 (10.8%)

 

Subcutaneous emphysema

6 (6.7%)

11 (11.8%)

 

Pleural effusion

32 (35.6%)

49 (52.7%)

< 0.05

Fusion in lung

2 (2.2%)

13 (13.8%)

 
  1. Data are median (Interquartile range) or n (%).
  2. Significant values are in [bold].
  3. ICU Intensive care unit, ANE-ICU Intensive care unit of the Department of Anesthesiology and Critical Care Medicine, UKD University hospital Dresden, DVT Deep vein thrombosis, VTE Thromboembolic complications, PE Pulmonary embolism.
Back to article page